Utilize este identificador para referenciar este registo: https://hdl.handle.net/10316/45150
Campo DCValorIdioma
dc.contributor.authorFiuza, S. M.-
dc.contributor.authorGomes, C.-
dc.contributor.authorTeixeira, L. J.-
dc.contributor.authorGirão da Cruz, M. T.-
dc.contributor.authorCordeiro, M. N. D. S.-
dc.contributor.authorMilhazes, N.-
dc.contributor.authorBorges, F.-
dc.contributor.authorMarques, M. P. M.-
dc.date.accessioned2017-12-15T18:54:10Z-
dc.date.available2017-12-15T18:54:10Z-
dc.date.issued2004-
dc.identifier.urihttps://hdl.handle.net/10316/45150-
dc.description.abstractThe antiproliferative and cytotoxic properties of polyphenolic acid derivatives, structurally related with the natural models caffeic and gallic acids, have been tested in human cervix adenocarcinoma cells (HeLa). Simultaneous structural information was obtained for these compounds through theoretical ab initio methods. This study was conducted for the following esters: methyl caffeate (MC, 1), propyl caffeate (PC, 2), octyl caffeate (OC, 3), methyl gallate (MG, 4), propyl gallate (PG, 5) and octyl gallate (OG, 6). A significant growth-inhibition effect was assessed for some of these compounds, clearly dependent on their structural characteristics. Marked structure-activity relationships (SARs)--namely the number of hydroxyl ring substituents--were found to rule the biological effect of such systems.por
dc.language.isoengpor
dc.rightsopenAccesspor
dc.subjectAntineoplastic Agentspor
dc.subjectCaffeic Acidspor
dc.subjectCell Linepor
dc.subjectCell Survivalpor
dc.subjectDrug Screening Assays, Antitumorpor
dc.subjectEsterspor
dc.subjectGallic Acidpor
dc.subjectHumanspor
dc.subjectHydroxybenzoatespor
dc.subjectInhibitory Concentration 50por
dc.subjectMethylationpor
dc.subjectMolecular Structurepor
dc.subjectStructure-Activity Relationshippor
dc.titlePhenolic acid derivatives with potential anticancer properties––a structure–activity relationship study. Part 1: Methyl, propyl and octyl esters of caffeic and gallic acidspor
dc.typearticle-
degois.publication.firstPage3581por
degois.publication.lastPage3589por
degois.publication.issue13por
degois.publication.titleBioorganic & Medicinal Chemistrypor
dc.peerreviewedyespor
dc.identifier.doi10.1016/j.bmc.2004.04.026por
dc.identifier.doi10.1016/j.bmc.2004.04.026-
degois.publication.volume12por
item.fulltextCom Texto completo-
item.grantfulltextopen-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.researchunitQFM-UC – Molecular Physical-Chemistry R&D Unit-
crisitem.author.orcid0000-0002-5171-0454-
crisitem.author.orcid0000-0002-8391-0055-
Aparece nas coleções:FCTUC Ciências da Vida - Artigos em Revistas Internacionais
Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato
BMC_04_12.pdf490.39 kBAdobe PDFVer/Abrir
Mostrar registo em formato simples

Citações SCOPUSTM   

298
Visto em 1/mai/2023

Citações WEB OF SCIENCETM
1

251
Visto em 2/jan/2022

Visualizações de página 50

440
Visto em 25/set/2024

Downloads 20

1.602
Visto em 25/set/2024

Google ScholarTM

Verificar

Altmetric

Altmetric


Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.